ReviewEJNMMI radiopharmacy and chemistry2021
Production of scandium radionuclides for theranostic applications: towards standardization of quality requirements.
Review in EJNMMI radiopharmacy and chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Energy dependent production and radionuclidic purity of [Formula: see text]from [Formula: see text]reactions: a combined theoretical and data from EXFOR library using the EMPIRE code.EJNMMI radiopharmacy and chemistry · 2026Article
- Radionuclide‑drug conjugates in lung cancer: advances in precision therapy and clinical translation.Molecular cancer · 2026Review
- Radiation stability and performance of TEHDGA resin for theranostic scandium radionuclide purification.EJNMMI radiopharmacy and chemistry · 2026Article
- A true theranostic pair -European journal of nuclear medicine and molecular imaging · 2026Article
- The gastrin-releasing peptide receptor in oncology: a comprehensive review of recent advances in targeted radionuclide theranostics.Frontiers in oncology · 2026Review
- Sc(III) Complexes of Pyclen Derivative Ligands as Probes for Hypoxia: Synthesis, Chemical Characterization,Chemistry (Weinheim an der Bergstrasse, Germany) · 2025Article
- [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025Article
- Synthesis of DOTA-BasedMethods and protocols · 2025Article
- Towards a dry separation method of radioscandium from bulk amounts of titanium.Journal of radioanalytical and nuclear chemistry · 2025Article
- Production of high purityEJNMMI radiopharmacy and chemistry · 2024Article
- Ionic Liquid-Based Extraction Strategy for the Efficient and Selective Recovery of Scandium.Molecules (Basel, Switzerland) · 2024Article
- Comparison of the dosimetry of scandium-43 and scandium-44 patient organ doses in relation to commonly used gallium-68 for imaging neuroendocrine tumours.EJNMMI physics · 2024Article
- Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues.International journal of molecular sciences · 2024Review
- Target Development towards First Production of High-Molar- ActivityPharmaceuticals (Basel, Switzerland) · 2024Article
- Nuclear Cross-Section of Proton-Induced Reactions on EnrichedPharmaceuticals (Basel, Switzerland) · 2023Article
- Scandium Radioisotopes-Toward New Targets and Imaging Modalities.Molecules (Basel, Switzerland) · 2023Review
- Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics.Molecules (Basel, Switzerland) · 2023Article
- RUNX3 regulates the susceptibility against EGFR-targeted non-small cell lung cancer therapy usingBMC cancer · 2023Article
- Radiochemistry for positron emission tomography.Nature communications · 2023Review
- Radiometallation and photo-triggered release of ready-to-inject radiopharmaceuticals from the solid phase.Chemical science · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the frame of "precision medicine", the scandium radionuclides have recently received considerable interest, providing personalised adjustment of radiation characteristics to optimize the efficiency of medical care or therapeutic benefit for particular groups of patients. Radionuclides of scandium, namely scandium-43 and scandium-44 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.